About Us

DR. ARTHUR MARTIN, CHIEF SCIENTIST FOR SATORI CLEAN AIR SYSTEMS

GICC LLC. President & Principal Research Scientist. USA.
BioKlyn Biotech. Chief Scientist. Tianjin, China.
Aisal Group of Companies. Infection Control Consultant. Riyadh Saudi Arabia.
Holista Colltech Ltd. Scientific Advisory Board. Kuala Lumpur, Malaysia.
World Health Organization. Stop T.B. Board. Geneva, Switzerland.
Infectious Disease International Research Initiative. Ankara, Turkey.
Camarines Norte State University Collaborative Researcher. Philippines

SATORI

About our Company

Dr. Arthur Martin created the technology behind Satori Clean Air Systems. He is a distinguished scientist whose groundbreaking work on COVID-19 has earned him a Nobel Prize nomination, stands as a globally recognized authority in the realm of disease and infection control technology. With a career spanning over three decades, he has gained a reputation as a highly sought consultant and expert in the selection of the most eﬃcient and effective technologies tailored to specific structures and applications. Dr. Martin has lent his expertise to over 20 countries as well as numerous government and private entities.

Having previously held membership in ASHRAE, Dr. Martin boasts a remarkable track record, with his past projects earning him prestigious first place awards in categories such as Existing Health Care and Existing Institutional Buildings. One of his notable projects was hailed as the Most Eﬃcient Building in the Nation. In his role as the Environmental Consultant to The Faisal Group of Companies in Riyadh, Kingdom of Saudi Arabia, he has played a pivotal role in addressing environmental challenges. Moreover, Dr. Martin serves as a valued member of the W.H.O. Stop TB board. He is a critical and dedicated researcher at the Infectious Diseases International Research Initiative in Ankara, Turkey, and a researcher with Camarines Norte State University in Daet, Philippines

Dr. Martin also holds the position of Chief Scientist at a biotechnology company in Tianjin, China, and is aﬃliated with STIMANOVA INTERNATIONAL – FZCO in Dubai, UAE. His remarkable contributions have not gone unnoticed, as he was previously nominated for the W.H.O Kochon Prize in recognition of his work on tuberculosis within buildings, which has significantly reduced treatment and enhanced the eﬃciency of treating infected individuals.

In 2021, Dr. Martin’s groundbreaking work on COVID-19 garnered a Nobel Prize nomination, highlighting his ingenuity and dedication to addressing pressing global health challenges. His pioneering eﬀorts led to the conceptualization, development, testing, and production of Organic Based Technology capable of swiftly eradicating COVID-19 and a multitude of other pathogens in under two minutes. This innovative solution was specifically designed to target pathogenic bioaerosols and VOCs, mitigating their impact and preventing them from becoming respirable, thus contributing to a safer and healthier world.